Research and development
Flow – sum over the period · $M
Q2 2017
13.5$M
All values (42)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 27.5 | reported |
| Q1 2026 | 27.5 | reported |
| Q4 2025 | 26.5 | derived |
| Q3 2025 | 25.4 | reported |
| Q2 2025 | 25.7 | reported |
| Q1 2025 | 26.0 | reported |
| Q4 2024 | 24.9 | derived |
| Q3 2024 | 23.2 | reported |
| Q2 2024 | 23.8 | reported |
| Q1 2024 | 24.8 | reported |
| Q4 2023 | 22.9 | derived |
| Q3 2023 | 21.7 | reported |
| Q2 2023 | 22.2 | reported |
| Q1 2023 | 24.2 | reported |
| Q4 2022 | 21.5 | derived |
| Q3 2022 | 21.0 | reported |
| Q2 2022 | 20.3 | reported |
| Q1 2022 | 22.9 | reported |
| Q4 2021 | 20.8 | derived |
| Q3 2021 | 19.6 | reported |
| Q2 2021 | 19.8 | reported |
| Q1 2021 | 20.3 | reported |
| Q4 2020 | 19.4 | derived |
| Q3 2020 | 19.7 | reported |
| Q2 2020 | 18.2 | reported |
| Q1 2020 | 17.4 | reported |
| Q4 2019 | 15.1 | derived |
| Q3 2019 | 14.6 | reported |
| Q2 2019 | 15.0 | reported |
| Q1 2019 | 16.1 | reported |
| Q4 2018 | 15.0 | derived |
| Q3 2018 | 13.7 | reported |
| Q2 2018 | 13.8 | reported |
| Q1 2018 | 15.4 | reported |
| Q4 2017 | 12.8 | derived |
| Q3 2017 | 12.7 | reported |
| Q2 2017 | 13.5 | reported |
| Q1 2017 | 13.3 | reported |
| Q4 2016 | 13.7 | derived |
| Q3 2016 | 14.3 | reported |
| Q2 2016 | 14.3 | reported |
| Q1 2016 | 16.7 | reported |
CSV with all sources · Technical ID: rnd
More metrics for VeriSign
Income statement
Balance sheet
Debt and interest
Sources & calculation
- Value
- $14.0M
- Period
- Q2 2017, ended Jun 30, 2017 · quarterly value (3 months, not cumulative)
- Source
- 10-Q, filed Jul 27, 2017 · 0001014473-17-000029
- Location
- us-gaap:ResearchAndDevelopmentExpense
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $14.0M | Jul 27, 2017 | 10-Q 0001014473-17-000029 | reported · confidence 1. · current |